High frequency of autoantibodies in patients
with primary sclerosing cholangitis that bind biliary epithelial cells
and induce expression of CD44 and production of interleukin 6
B Xu1, U Broome2, B-G Ericzon3 and S Sumitran-Holgersson1
1 Division of Clinical Immunology F-79, Huddinge
University Hospital. S-141 86 Huddinge, Sweden
2 Division of Gastroenterology K-63, Huddinge University Hospital,
S-141 86 Huddinge, Sweden
3 Transplantation Surgery at the Karolinska Institute, Huddinge University
Hospital, S-141 86 Huddinge, Sweden
Correspondence to:
Dr S Sumitran-Holgersson, Division of Clinical Immunology, F-79,
Karolinska Institutet, Huddinge University Hospital AB, S-141 86
Stockholm, Sweden
suchitra.holgersson@impi.ki.se
Aim: Sera of patients with autoimmune
liver diseases were investigated for the presence of autoantibodies
binding to human biliary epithelial cells (BECs). Furthermore, their
functional capacity was investigated by testing their capacity to
fix complement as well as induce expression of various adhesion
molecules and production of cytokines.
Methods: Sera from patients with
various stages of primary sclerosing cholangitis (PSC; n=30), primary
biliary cirrhosis (PBC; n=29), autoimmune hepatitis (AIH; n=25),
and normal controls (n=12) were investigated for the presence of
antibodies that reacted with unstimulated and cytokine stimulated
BECs isolated from a normal healthy liver. To demonstrate organ
specificity, lung epithelial cells (LECs) were used as control cells.
Antibodies were tested for their functional capacity.
Results: Compared with controls (8%),
significantly higher numbers of PSC patients (63%, p=0.001), but
not PBC (37%, NS) or AIH (16%, NS) patients, had anti-BEC antibodies.
In 90% of PSC patients, the autoantibodies reacted only with cytokine
stimulated target cells. Lower numbers of PSC (6%), PBC (10%), and
AIH (0%) patients had LEC antibodies. Other significant findings
were that anti-BEC antibodies were found in (i) PSC patients with
either the HLA-DRB1*0301 or DR2 allele compared with those without
(p=0.007); and (ii) in PBC patients with end stage disease compared
with those without (p=0.018). Furthermore, anti-BEC antibodies from
PSC and PBC but not AIH patients induced BECs to produce high levels
of the cytokine interleukin 6. IgM and IgG fractions isolated from
PSC but not PBC and AIH sera induced significantly increased expression
of the cell adhesion molecule CD44. Sodium dodecyl sulphate-polyacrylamide
gel electrophoresis and western blot analysis of BEC membranes demonstrated
a specific band of 40 kDa with PSC sera and 45, 42, 30, and 33 kDa
bands with PBC sera, which were absent in control groups.
Conclusion: Thus for the first
time we have demonstrated the presence of functionally important
autoantibodies to cell surface expressed antigens on the relevant
target cells of destruction, namely BECs, in PSC and PBC. These
finding have important implications for the pathogenesis of bile
duct destruction in these patients.
|